A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/365 (2006.01) A61K 31/135 (2006.01)
Patent
CA 2375972
A method for the treatment of co-morbid conditions associated with obesity in a human in need of such treatment which comprises administration to the human of a therapeutically effective amount of a compound of formula (I) including enantiomers and pharmaceutically acceptable salts thereof, in which R1 and R2 are independently H or methyl, and a therapeutically effective amount of a compound of formula (II) wherein the compound of formula (I) and the compound of formula (II) are administered simultaneously, separately or sequentially.
Cette invention a trait à une méthode de traitement d'états co-morbides liés à l'obésité chez l'homme, laquelle méthode consiste à administrer une quantité efficace du point de vue thérapeutique d'un composé correspondant à la formule (I) et renfermant des énantiomères et leurs sels, admissibles du point de vue pharmaceutique. Dans cette formule, R¿1? et R¿2? représentent, indépendamment, un hydrogène ou un méthyle. Cette méthode repose également sur l'administration d'une quantité efficace du point de vue thérapeutique d'un composé correspondant à la formule (II). Ces deux composés sont administrés simultanément, séparément ou successivement.
Abbott Gmbh & Co. Kg
Knoll Aktiengesellschaft
Robic
LandOfFree
Pharmaceutical composition containing sibutramine and orlistat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition containing sibutramine and orlistat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition containing sibutramine and orlistat will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1883635